SCHEMBL26917372

SCHEMBL26917372

C[C@@H](N)c1ncccc1C#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 8/20 0.46
▸ ALDH1A1 P00352 8/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ POLB P06746 1/20 0.45
▸ KDM4E B2RXH2 3/20 0.43
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ GAA P10253 2/20 0.40
▸ CYP3A4 P08684 1/20 0.39
▸ LRRK2 Q5S007 1/20 0.39
▸ TSHR P16473 1/20 0.36
▸ ELANE P08246 1/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.35
▸ MAPT P10636 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26917374 1.00 HPGD (0.46) HPGDALDH1A1SMN1; SMN2NPC1RAB9A
Hydrochloric Acid SCHEMBL26917236 0.98 HPGD (0.45) HPGDALDH1A1SMN1; SMN2NPC1RAB9A
Hydrochloric Acid SCHEMBL26917240 0.98 HPGD (0.45) HPGDALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL2627822 0.86 HPGD (0.53) HPGDALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL1331893 0.79 HPGD (0.44) HPGDALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL10120091 0.79 HPGD (0.56) HPGDALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL18424315 0.78 KDM4E (0.43) HPGDALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL19762501 0.77 HPGD (0.41) HPGDALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL31445694 0.76 ALDH1A1 (0.46) HPGDALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL27966456 0.74 PLCG1 (0.39) HPGDALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4288437-A1 MAP4K1 INHIBITORS Bayer Aktiengesellschaft (DE) 2023-12-13 — — EP disclosed
Send feedback